APA (7th ed.) Citation

DM, H., E, S., J, A. A., JE, B. R., C, C., R, E., . . . A, N. D. P. (2017). Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays. Journal of surgical oncology, 115(6), 647. https://doi.org/10.1002/jso.24561

Chicago Style (17th ed.) Citation

DM, Hyams, et al. "Selecting Postoperative Adjuvant Systemic Therapy for Early Stage Breast Cancer: A Critical Assessment of Commercially Available Gene Expression Assays." Journal of Surgical Oncology 115, no. 6 (2017): 647. https://doi.org/10.1002/jso.24561.

MLA (9th ed.) Citation

DM, Hyams, et al. "Selecting Postoperative Adjuvant Systemic Therapy for Early Stage Breast Cancer: A Critical Assessment of Commercially Available Gene Expression Assays." Journal of Surgical Oncology, vol. 115, no. 6, 2017, p. 647, https://doi.org/10.1002/jso.24561.